Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

Bits & Pretzels

Events
Bits & PretzelsG2B

Catapult has been an extensive journey that started approximately more than one year ago, filled with valuable lessons and challenges. It all began with our decision to apply, and upon receiving the news of our acceptance into the program, we embarked on this transformative experience.

Progressing through the stages, Gate2Brain emerged successfully, earning a spot among the 30 startups representing the region in the program’s semifinals. This phase entailed receiving remarkable individual training from a panel of globally renowned health experts to refine our pitch deck and business model, among them our EIT Health’s mentor, Dirk Groenewegen, to whom we’re deeply thankful for his invaluable expertise and advice that accompanied us every step of the way. Additionally, we had the privilege of participating in a Get Together event held in Paris, where we had the opportunity to meet all the Catapult semifinalists in person over two days. This event presented a fantastic chance to foster synergies and forge meaningful connections. Our expedition continued as we presented our project to an investor jury, ultimately being chosen as a runner-up finalist to attend Bits & Bretzels and pitch our venture.

Bits & Pretzels

 

Along this journey, we had the chance to engage with corporates, venture capitalists, and an entire ecosystem deeply invested in fostering social impact by supporting startups like Gate2Brain. Moreover, we were fortunate to witness the presence of Michael J. Fox, an iconic figure and idol for our most veteran team members

We’re grateful for the opportunity to be part of this remarkable expedition, where we have had the privilege of encountering remarkable individuals driven by the shared goal of making significant strides in improving people’s lives

 

The quality of the submitted projects was truly exceptional, and we extend our heartfelt congratulations to all the startups that took part in this program and to the nine winners.

At Gate2Brain, we’re leveraging this momentum and persevering on our pursuit of bringing medicines beyond barriers.

June 22, 2023/by noticias
Tags: Bits&Bretzels, eithealth
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/06/BB-Munich5.jpeg 1024 768 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-06-22 12:15:402023-06-22 12:21:04Bits & Pretzels
You might also like
Press clippingg2bPress-Clipping – Gate2Brain receives €2,5M funding to develop a technology that enhances drug delivery to the brain

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
17th China International Peptide Academic Symposium17th China International Peptide Academic Symposium10 Top Biotech Startups to Watch in 2023StartUs10 Top Biotech Startups to Watch in 2023
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}